share_log

嘉必优(688089.SH):基于合成生物学技术,公司目前已经开发出系列HMO产品

Jia Biyou (688089.SH): Based on synthetic biology technology, the company has now developed a series of HMO products

Gelonghui Finance ·  May 16 05:08

Gelonghui, May 16, 丨 Jia Biyou (688089.SH) said on the investor interactive platform that with technological innovation as the fundamental driving force, the company has opened up the entire synthetic biology technology chain, gradually formed a biological data analysis and processing platform with computational biology and bioinformatics as the core technical capabilities, a biosynthetic platform with genetic engineering, metabolic engineering, enzyme engineering, and cell engineering as the core technical capabilities, and visual analysis of cell biology, biomedicine, and multidimensional omics as the core competencies. From product development to application technology, the company's synthetic biology research and development technology Capabilities have been further enhanced. Based on synthetic biology technology, the company has now developed a series of HMO products.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment